Company: MBIO
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001104659-25-108468
Chunk: 18

Company: MUSTANG BIO, INC.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 4C
Chunk 18
---
Item 4. Controls and Procedures

​

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive and financial officer, we conducted an evaluation of the effectiveness, as of September 30, 2025, of the design and operation of our disclosure controls and procedures, as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on this evaluation, our principal executive and financial officer concluded that, as of such date, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our principal executive and financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

No change in internal control over financial reporting occurred during the most recent quarter, with respect to our operations, which materially affected, or is reasonable likely to materially affect, our internal controls over financial reporting.

​